Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Effect of B. longum + Gl-OS on seroprotection status in young and older subjects before and 4 weeks after influenza vaccination

From: Effect of a synbiotic on the response to seasonal influenza vaccination is strongly influenced by degree of immunosenescence

 

Seroprotection status

 

Vaccine strain

 

Young cohort (n = 58)

Older cohort (n = 54)

p

  

Placebo

B. longum + Gl-OS

Placebo

B. longum + Gl-OS

 
  

n/N (%)

n/N (%)

n/N (%)

n/N (%)

 

A/California/7/2009 (H1N1)

Before

20/29 (69)a

13/29 (45)a

5/28 (18)

1/26 (4)

< 0.001

After

29/29 (100)

27/29 (93)a

22/27 (81)

16/26 (62)

< 0.001

A/Perth/16/2009 (H3N2)

Before

10/29 (34)

13/29 (45)

8/28 (29)

12/26 (46)

NS

After

26/29 (90)

27/29 (93)

25/27 (93)

22/26 (85)

NS

B/Brisbane/60/2008

Before

4/29 (14)

0/29 (0)

4/24 (17)

5/26 (19)

NS

After

28/29 (97)

20/29 (76)

14/27 (52)

11/26 (42)

< 0.001

  1. Data are numbers of seroprotected (n)/total (N) and % seroprotected subjects in parentheses. ‘Before’ refers to week 4 samples and ‘After’ refers to week 8 samples (ie 4 weeks after vaccination). P refers to results of Fisher’s exact test for differences between the cohorts with treatment groups combined; ayoung cohort significantly different from the older cohort within same treatment group (p < 0.01, Fisher’s Exact test)